報價延遲最少15分鐘:2025/04/30 01:35 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.283 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-4.33/3.14
|
|
企業價值
1.83M
|
| 資產負債 |
|
每股賬面淨值
0.17
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
787.00K
|
|
每股收益
0.14
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/04/30 01:35 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise. |